| 000 | 01185 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513203201.0 | ||
| 264 | 0 | _c20000316 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a1040-8746 | ||
| 024 | 7 |
_a10.1097/00001622-200001000-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoehm-Viswanathan, T | |
| 245 | 0 | 0 |
_aIs angiogenesis inhibition the Holy Grail of cancer therapy? _h[electronic resource] |
| 260 |
_bCurrent opinion in oncology _cJan 2000 |
||
| 300 |
_a89-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aCell Transformation, Neoplastic |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypoxia |
| 650 | 0 | 4 |
_aLymphokines _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xphysiopathology |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 773 | 0 |
_tCurrent opinion in oncology _gvol. 12 _gno. 1 _gp. 89-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001622-200001000-00015 _zAvailable from publisher's website |
| 999 |
_c10641969 _d10641969 |
||